USER FEE REAUTHORIZATION BILL IS FIRST INDUSTRY PRIORITY FOR 105th CONGRESS; FDA MAY SEEK TO PREEMPT REFORM DEBATE WITH OWN PROPOSAL FOR CONSENSUS CHANGES
Executive Summary
Participants in the user fee reauthorization negotiations hope to reach agreement on a bill to extend the Prescription Drug User Fee Act in time for the opening of the 105th Congress.